All Patient Refined Diagnosis Related Groups (APR-DRGs) : Definitions Manual [printed text] / Richard F. Averill, Publishing director ; Norbert Goldfield, Expert ; Barbara A. Steinbeck, Publishing director ; Thelma Grant, Publishing director . - Version 15.0 . - Wallingford [United States of America] : 3M Health Information Systems, 1998 . - 3 Volumes; vol.1: 939 p., vol.2: 1065 p., vol.3: 605 p : Loose Leaves ; 29 cm + 3M Software. Loose-leaf publication Languages : English ( eng)
| Descriptors: |
Classification
WX 157.8 Diagnosis-related groups
Indexation
Classification ; Diagnosis-Related Groups ; Handbooks ; Hospitals ; Loose-leaf publications ; Manuals ; Patients ; Prospective Payment System ; United States
|
| Abstract: |
When it comes to adjusting your data for severity of illness or risk of mortality, 3M Health Information Systems sets the standard with the 3M APR DRG Classification System. Used for comparative profiling, clinical pathway development and quality assurance, managed care contracting, coder productivity, strategic planning and setting capitation rates, the 3M APR DRG Classification System is assigned using information available from the standard UB-92 (i.e. diagnoses, procedures, age, sex, and discharge status).
You can use the 3M APR DRG Classification System or the 3M™ APR™ DRG Software to prepare for the release of comparative provider reports published by state agencies. For the comparisons to be meaningful, they need to be adjusted for differences in severity of illness and risk of mortality. As a result, when state hospital agencies need to standardize on a severity system, most choose the 3M APR DRG Classification System. |
| Record link: |
https://kce.docressources.info/index.php?lvl=notice_display&id=419 |
|  |
Add the result to your basket Make a suggestion Refine your search Apply to external sources2011 Survey of Health Care Consumers Global Report / Deloitte Development (2011)
3M™ APR DRG Software / Wallingford [United States of America] : 3M Health Information Systems (2008)
Endpoints for relative effectiveness assessment (REA) of pharmaceuticals in International Journal of Technology Assessment in Health Care, 30(2014)05 ([11/01/2014])
